Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.
Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision updated from Revision: v3.2.0 to Revision: v3.3.2 on the page; no study data or content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedThe page removed a non-substantive government funding notice about operating status and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check43 days agoChange DetectedTwo screenshots show only a visual/layout refresh of the Study Details page; core content such as the title, conditions, endpoints, enrollment, and eligibility criteria remains the same. If anything changed, it would be only cosmetic, with no additions or removals of critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check71 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference4%
- Check78 days agoChange DetectedReleased a new version: v3.1.0, replacing the old v3.0.2. This is a core content update (version number) with no other substantive additions or deletions.SummaryDifference0.1%
- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.